Clinical Efficacy of Axillary Block in Cervical Radiculopathy

February 13, 2023 updated by: Ji Hee Hong, Keimyung University Dongsan Medical Center

Comparison of Clinical Efficacy of Axillary Block in Patients of Cervical Radiculopathy

The primary endpoint of this study was to compare the clinical efficacy of axillary block in patients of cervical radiculopathy using 2 volumes of local anesthetics.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The interscalene brachial plexus block is an effective intervention for reducing postoperative pain but is related to side effects, Suprascapular nerve block and a block of the axillary nerve have been introduced as alternatives to the interscalene brachial plexus for the control of postoperative pain. Previous study demonstrated new method of axillary block using interfascial plane injection guided by ultrasoud. Axillary block has been used widely for the relief of postoperative arm pain.

Recent study deomonstrated good pain relief when ultrasound guided interfascial plane injection was performed in patients with cervical radiuculopathy.

There is no study showing clinical efficacy of interfascial plane injection of axillary block in patients of cervical radiculopathy.

Study Type

Interventional

Enrollment (Anticipated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Cervical foraminal stenosis
  • Cervical central stenosis
  • Cervical disc herniation
  • Cervical spondylolisthesis
  • Prominent arm pain rather than neck pain

Exclusion Criteria:

  • Infection
  • Pregnancy
  • allergy to local anesthetic agents
  • previous cervical spine surgery
  • Prominent neck pain rather than arm pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 5ml axillary block group
interfascial plane axillary block group using 5 ml local anesthetics
Procedure: axillary block guided by ultrasound
axillary block using local anesthetics
Active Comparator: 10ml axillary block group
interfascial plane axillary block group using 10 ml local anesthetics
Procedure: axillary block guided by ultrasound
axillary block using local anesthetics

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numerical rating scale changes among 4 time periods
Time Frame: baseline, 2 weeks after injection, 4 weeks after injection, 8 weeks after injection
Numerical rating scale changes among 4 time periods
baseline, 2 weeks after injection, 4 weeks after injection, 8 weeks after injection
Neck disability injex changes between 2 time periods
Time Frame: baseline, 8 weeks after injection
Neck disability injex changes between 2 time periods
baseline, 8 weeks after injection

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Keimyung University Dongsan Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2023

Primary Completion (Anticipated)

November 30, 2023

Study Completion (Anticipated)

November 30, 2023

Study Registration Dates

First Submitted

February 3, 2023

First Submitted That Met QC Criteria

February 3, 2023

First Posted (Actual)

February 10, 2023

Study Record Updates

Last Update Posted (Actual)

February 15, 2023

Last Update Submitted That Met QC Criteria

February 13, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023-01-025-05

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Chronic

Clinical Trials on axillary block guided by ultrasound

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe